A method for mass spectrometry detection of volatile organic metabolites in urine
By using headspace sampling-rapid gas chromatography-combined photoionization time-of-flight mass spectrometry, the matrix interference problem of volatile organic metabolites in urine has been solved, enabling rapid and accurate detection of volatile organic metabolites in urine, simplifying sample pretreatment, and supporting early diagnosis of diseases.
Patent Information
- Application Number
- CN202510588633.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-08
- Publication Date
- 2026-11-10
AI Technical Summary
Existing mass spectrometry techniques for detecting volatile organic metabolites in urine suffer from matrix interference, leading to inaccurate results and complex sample pretreatment, making it difficult to achieve early screening for related diseases.
The headspace sampling-rapid gas chromatography-time-of-flight mass spectrometry (GC-MS) technique, combined with gas chromatography-mass spectrometry, was used to detect volatile organic metabolites in urine via an autosampler and a GC-MS instrument, simplifying the sample pretreatment process.
This technology enables rapid and accurate detection of volatile organic metabolites in urine, simplifies sample pretreatment steps, improves detection efficiency and result reliability, and provides technical support for the early diagnosis of related diseases.
Smart Images

Figure CN123066239A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of analytical chemistry instruments, specifically relating to a method for detecting volatile organic metabolites in urine using headspace sampling-rapid gas chromatography-composite photoionization mass spectrometry. Background Technology
[0002] In the human body, volatile organic metabolites (VOMs) produced by cellular metabolism are metabolized through blood circulation, pulmonary gas exchange, intestinal digestion, and metabolism by the bladder, sweat glands, and salivary glands, ultimately appearing in the blood, exhaled air, urine, sweat, and feces. It is well known that diseases alter an individual's physiological and metabolic state, and under pathological conditions, changes in the concentration of VOMs or the formation of new VOMs are often associated with them. Currently, more than 1800 VOMs have been identified in the human body, including hydrocarbons, aldehydes and ketones, alcohols, phenols, sulfur-containing compounds, and nitrogen-containing compounds. Many studies have focused on using VOM analysis to diagnose diseases such as diabetes, ulcerative colitis, asthma, chronic obstructive pulmonary disease, and irritable bowel syndrome, especially for the early diagnosis of cancer. Therefore, the analysis and detection of small-molecule volatile organic metabolites to assist in the early screening and diagnosis of diseases is of great significance and has broad prospects.
[0003] Urine has a complex composition, containing not only inorganic substances such as water, inorganic salts, and urea, but also cells, exosomes, proteins, peptides, and metabolites depending on physiological processes. Compared to other bodily fluids, urine is a bodily fluid that can be obtained in large quantities non-invasively from a patient, even several times a day, allowing for the control of biomarker concentrations at specific times. For this reason, human urine plays a crucial role in the analysis of various diseases. Urine can provide information about kidney disease and the urinary tract, and can also provide metabolic information from other organs and more distant organs through glomerular filtration. Therefore, urine has broad prospects in biomarker identification and is of great value in the diagnosis, prognosis, and follow-up of treatment responses in human pathology.
[0004] There is considerable research on diagnosing certain diseases, particularly cancer, by detecting volatile organic metabolites in urine. Commonly used detection methods include chemical sensors, nuclear magnetic resonance spectroscopy (NMR), ion mobility spectrometry (IMP), and mass spectrometry (MS). Chemical sensors are small, low-cost, and have a fast response, but they are easily affected by background interference and have relatively low sensitivity and poor sample qualitative ability. NMR spectroscopy excels in qualitative ability, but it has high sample requirements and relatively low detection sensitivity. Ion mobility spectrometry's greatest advantage is its fast detection speed and high sensitivity, but it has lower selectivity and resolution, and weaker qualitative analysis ability. Compared to other techniques, mass spectrometry can directly obtain the molecular weight information of the sample, enabling direct qualitative and quantitative analysis of compounds. It is the most widely researched and applied technique in the field of analytical testing, and its analytical results have become a recognized standard.
[0005] Urine, as a complex liquid sample, cannot be directly analyzed by chromatography or mass spectrometry. Pretreatment and appropriate injection methods are typically required to detect volatile organic metabolites (VOMs) in urine. This invention develops an analytical method for mass spectrometry detection of VOMs in urine, enabling rapid analysis of large batches of urine samples with accurate and reliable results, providing a technical means for the diagnosis of related diseases. Summary of the Invention
[0006] To address the shortcomings of existing mass spectrometry methods for detecting volatile organic metabolites in urine, this invention aims to provide a method suitable for mass spectrometry detection of volatile organic metabolites in urine, solving the problem of matrix interference in urine and providing technical means and analytical detection methods for the early screening of related diseases such as bladder cancer. This invention employs headspace sampling and purge technology combined with gas chromatography-mass spectrometry to develop a method for detecting disease-related volatile organic metabolites in urine, providing a new technical approach for the early diagnosis of related diseases.
[0007] To achieve the above objectives, this invention application adopts the following technical solution:
[0008] A method for detecting volatile organic metabolites in urine by mass spectrometry, wherein the method employs headspace autosampler-gas chromatography-combined photochemical ionization-combined photoionization time-of-flight mass spectrometry. The detection process is as follows: a pretreated urine sample is placed in a headspace autosampler, and the sampler is equilibrated, pressurized, and filled with a quantitative loop. Nitrogen gas is then used as a carrier gas to purge the sample into a rapid gas chromatograph, where rapid gas chromatography-combined photoionization time-of-flight mass spectrometry is used for detection.
[0009] (1) The detection was performed using headspace autosampling-rapid gas chromatography-combined photoionization time-of-flight mass spectrometry, with the specific detection conditions set as follows:
[0010] The headspace autosampler has an equilibrium temperature of 25-90℃ (preferably 40-80℃), an equilibrium time of 1-8 min (2-6 min), a pressurization time of 30-120 s (preferably 50-100 s), an injection time of 10-50 s (preferably 20-40 s), a sampling time of 10-50 s (preferably 20-40 s), and a nitrogen carrier gas flow rate of 7.8-46.8 ml / min.
[0011] The gas chromatograph injection port is set at 90-150℃ (preferably 110-140℃); the chromatographic column is a polar column DB-WAX / HP-WAX (polyethylene glycol, PEG), DB-FFAP (nitroterephthalic acid modified PEG) or FFAP (N,N-dimethyl-N-(p-fluorophenyl)-3-aminopropionic acid), preferably FFAP (N,N-dimethyl-N-(p-fluorophenyl)-3-aminopropionic acid); the chromatographic carrier gas is He, nitrogen, hydrogen or argon, preferably helium; the flow rate is 10-20 mL / min; the split ratio is 0-5:1; the column oven is set at a constant temperature of 90-130℃; the temperature of the gas chromatograph interface transfer tube is 110-160℃.
[0012] The conditions for the photoionization time-of-flight mass spectrometer were as follows: a vacuum ultraviolet light source was used for the photoionization source; the bubbling flow rate of high-purity helium in water was 50-200 mL / min; and the gas pressure in the ionization region was 1.0 × 10⁻⁶. 2 -5.00×10 2 Pa, ion source temperature 110-150℃, gas chromatography-mass spectrometry single collection time is 1-5s;
[0013] (2) Detection of urine samples: Take 0.5-7 ml of pretreated urine sample and place it in the headspace autosampler. After the autosampler is balanced, pressurized and filled with a quantitative loop, nitrogen is used as the carrier gas to purge the sample into the injection port of the rapid gas chromatograph. The sample is analyzed by a rapid gas chromatography-composite photoionization mass spectrometer. The volatile organic metabolites in the urine are identified by comparing the retention time and mass-to-charge ratio of the sample and the standard.
[0014] Urine samples were collected from the subjects' first morning urine, and all subjects fasted for 6-8 hours before collection. After collection, the urine samples were stored in a -80°C refrigerator.
[0015] The pretreatment of urine samples is as follows: Urine samples are removed from a -80℃ freezer and then placed in an incubator before being transported to the laboratory for testing. The urine samples are thawed at 4℃ and then aliquoted in an ice-water bath. 2-8 mL of urine sample is added to a 2-10 mL glass vial (Shanghai Gulei Instrument Co., Ltd.), followed by 65-150 μL of a 2-6 mol·L⁻¹ solution. -1Adjust the pH of the urine to 1-2 with HCl, then add 0.5-1.5g of 99.8% pure NaCl, shake to dissolve, and store in the refrigerator for testing.
[0016] Take an appropriate amount of the prepared urine sample into a sample vial, then immediately tighten the cap and place the vial in a temperature-controlled headspace sampler. The sample is purged with nitrogen carrier gas through the sampler to the column oven, and negative pressure sampling is applied to the mass spectrometer inlet. Data acquisition by the mass spectrometer begins immediately. After 2 minutes of signal accumulation, the full spectrum of small-molecule volatile organic metabolites in the urine is obtained. The entire analysis process takes approximately 4 minutes. During the experiment, to prevent analytes from condensing in the tubing, all transfer tubing was heated to 100°C. Additionally, after each experiment, 100 mL / min was used to precipitate the sample. -1 High-purity nitrogen gas is used to clean the transmission pipeline to ensure a clean background.
[0017] The urine volume is 0.5-7 ml, the equilibration temperature of the injector is 40-90℃, the equilibration time is 1-8 min, and the carrier gas flow rate is 3-18 psi.
[0018] Compared with the prior art, the advantages of the technical solution of this invention are as follows: the headspace sampling-rapid gas chromatography-composite photoionization mass spectrometry detection method for volatile organic metabolites in urine does not require complicated sample pretreatment and a large amount of organic solvents. Acid and alkali are directly added to the urine, and then quantitative detection is performed using headspace sampling incubation-gas chromatography-composite photoionization mass spectrometry.
[0019] Urine samples, prepared through pretreatment, are placed in a headspace sampler. The sampler is equilibrated, pressurized, and a quantitative loop is filled. Nitrogen gas is then used as a carrier gas to purge the sample to the column oven. Under pressure differential, the sample enters the mass spectrometer tubing, where VUV lamp irradiation generates ions. These ions undergo continuous transport and shaping within the mass spectrometer, eventually reaching the field-free flight region and then the mCP detector. After signal amplification, the signal is transmitted to the acquisition card, yielding a mass spectrum of time-of-flight versus signal intensity, which is then converted into a mass-to-charge ratio versus intensity mass spectrum. Attached Figure Description
[0020] Figure 1 This invention relates to a headspace sampling-rapid gas chromatography-composite photoionization mass spectrometry (HPS-MS) instrument for detecting volatile organic metabolites in urine.
[0021] Figure 2 The mass spectra of volatile organic metabolites obtained from urine samples in the examples. Detailed Implementation
[0022] In this example, headspace sampling-rapid gas chromatography-combined photoelectroionization mass spectrometry was used to detect volatile organic metabolites in the urine of a test volunteer.
[0023] The tests were performed using a headspace sampling-rapid gas chromatography-combined photoelectroionization mass spectrometer, equipped with an autosampler (Beijing Juxin Zhuifeng Technology Co., Ltd., model Acrichi). The DK806A chromatogram was prepared with the following parameters: equilibrium temperature 70℃, equilibrium time 4 min, pressurization time 60 s, injection time 30 s, sampling time 20 s, and nitrogen carrier gas flow rate 26 ml / min. The gas chromatograph injection port was set to 135℃, the column was FFAP (N,N-dimethyl-N-(p-fluorophenyl)-3-aminopropionic acid), dimensions 30 μm * 0.53 mm * 1.0 μm, the carrier gas was He, flow rate 10 psi (17 ml / min), split ratio 0, column oven set to 110℃ for constant temperature testing, and the gas chromatography-mass spectrometry (GC-MS) interface transfer tube temperature set to 140℃. The photoionization time-of-flight mass spectrometer conditions were: vacuum ultraviolet photoionization source (high-purity helium gas was bubbled into water and then introduced into the ionization zone, high-purity helium flow rate 100 mL / min), ionization zone pressure 2.5 × 10⁻⁶ m / min. 2 Pa, ion source temperature 130℃, gas chromatography-mass spectrometry single-sampling time is 1s.
[0024] Urine samples were collected from the subject's first morning urine (20 mL). Subjects fasted for 6-8 hours prior to sample collection. After collection, the samples were stored at -80°C. The samples were then removed from the -80°C freezer and placed in an insulated container before being transported to the laboratory for testing. After thawing in a 4°C ice-water bath, the urine samples were aliquoted. 4.0 mL of urine sample was added to separate 5 mL glass vials (Shanghai Gulei Instrument Co., Ltd.), followed by the addition of 100 μL of a 4 mol·L⁻¹ solution to each vial. -1 The urine pH was adjusted to 1.5 with HCl, and then 1.0g of 99.8% pure NaCl was added. After shaking to dissolve, the solution was stored in the refrigerator for testing.
[0025] Take the sample to be tested, add 0.3g NaCl and 20μl of dilute hydrochloric acid solution respectively, then add 1μl of 100ppm internal standard chlorobenzene solution and mix well. Take 1ml and put it into the headspace vial of the headspace sampler. Equilibrate, pressurize and fill the quantitative loop through the sampler, then purge with nitrogen as carrier gas to the column oven. Then, under the action of pressure difference, enter the rapid gas chromatograph for separation and analysis. The total ion current of VOMs in urine is measured. Then, each component is irradiated by VUV lamp to generate ions. In the mass spectrometer, the ions undergo continuous transport and shaping, and finally reach the fieldless flight region, and then finally reach the mcp detector. After signal amplification, it is transmitted to the acquisition card to obtain the mass spectrum between time of flight and signal intensity, and finally converted into a mass spectrum between mass-to-charge ratio and intensity, as shown in the figure. Figure 2As shown, VOM metabolites in urine were identified by comparing the retention times and mass-to-charge ratios of compounds detected in the sample with those of standards. Chlorobenzene (m / z = 113) was detected, eluting at 101 s. Other substances in urine included ethyl acetate (m / z = 88), butanone (m / z = 73), allyl methyl sulfide (m / z = 88), 2-hexanone (m / z = 101), dimethyl disulfide (m / z = 72), ethylbenzene (m / z = 107), 2-heptanone (m / z = 115), 2-octanone (m / z = 128), anisole (m / z = 108), 2-methylthiophene (m / z = 88), and benzaldehyde (m / z = 128). The elution times of the samples ( / z=107) were 51s, 56s, 56s, 69s, 70s, 79s, 88s, 122s, 154s, 170s, and 321s, respectively. The results are shown in Table 1. Chromatography can achieve a good separation effect for different volatile organic metabolites. Headspace injection-rapid gas chromatography-composite photoionization time-of-flight mass spectrometry can effectively detect volatile organic metabolites in urine without the need for complicated sample pretreatment and large amounts of organic solvents.
[0026] Table 1. Peak times and mass-to-charge ratios of volatile organic metabolites detected in urine.
[0027]
Claims
1. A method for mass spectrometry detection of volatile organic metabolites in urine, characterized in that: The method uses headspace autosampler-rapid gas chromatography-combined photoionization time-of-flight mass spectrometry for detection. The pre-treated urine sample is placed in the headspace autosampler, and after the autosampler is equilibrated, pressurized, and filled with a quantitative loop, nitrogen is then used as a carrier gas to purge the sample into the rapid gas chromatograph. The rapid gas chromatography-combined photoionization time-of-flight mass spectrometry is used for detection. (1) The detection was performed using headspace autosampling-rapid gas chromatography-combined photoionization time-of-flight mass spectrometry, with the specific detection conditions set as follows: The headspace autosampler has an equilibration temperature of 25-90℃ (preferably 40-80℃), an equilibration time of 1-8 min (2-6 min), a pressurization time of 30-120 s (preferably 50-100 s), an injection time of 10-50 s (preferably 20-40 s), and a sampling time of 10-50 s (preferably 20-40 s). The nitrogen carrier gas flow rate is 7.8-46.8 ml / min. The gas chromatograph injection port has a temperature of 90-150℃ (preferably 110-140℃). The chromatographic column is a polar column, DB-WAX / HP-WAX (polyethylene glycol, PEG) or DB-FFAP (nitro-terephthalic acid modified). The chromatographic sample is prepared using PEG or FFAP (N,N-dimethyl-N-(p-fluorophenyl)-3-aminopropionic acid), preferably FFAP (N,N-dimethyl-N-(p-fluorophenyl)-3-aminopropionic acid). The carrier gas for the chromatographic injection is He, nitrogen, hydrogen, or argon, preferably helium. The flow rate is 10-20 mL / min; the split ratio is 0-5:1; the column oven is set to a constant temperature of 90-130℃; the temperature of the GC-MS transfer tube is 110-160℃; the photoionization time-of-flight mass spectrometer conditions are: vacuum ultraviolet light as the photoionization source, a bubble flow rate of 50-200 mL / min for high-purity helium in water, and a gas pressure of 1.0 × 10⁻⁶ ppm in the ionization zone. 2 -5.00×10 2 Pa, ion source temperature 110-150℃, gas chromatography-mass spectrometry single collection time is 1-5s; (2) Detection of urine samples: Take 1-10 ml of pretreated urine sample and place it in the headspace autosampler. After the autosampler is balanced, pressurized and filled with a quantitative loop, nitrogen is used as the carrier gas to purge the sample into the injection port of the rapid gas chromatograph. The sample is analyzed by a rapid gas chromatography-composite photoionization-mass spectrometer. The volatile organic metabolites in the urine are identified by comparing the retention time and mass-to-charge ratio of the sample and the standard.
2. The method according to claim 1, characterized in that: Urine samples were taken from the subjects' first morning urine, and all subjects fasted for 6-8 hours before collection.
3. The method according to claim 1, characterized in that: Urine pretreatment is as follows: Add 2-12 mL of urine sample to a 1-20 mL glass bottle, then add 50-200 μL of a 1-7 mol·L⁻¹ solution to the glass bottle. -1 Adjust the pH of the urine to 0.5-3 with HCl, then add 0.1-2.0g of 99.8% pure NaCl, shake to dissolve, and store in the refrigerator for testing.
4. The method according to claim 1, characterized in that: The headspace autosampler-rapid gas chromatography-compound photoionization-mass spectrometer includes an automatic headspace sampler, a chromatographic column oven, an injector connecting the autosampler and the column oven, and a photoionization time-of-flight mass spectrometer.
